A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 536 participants.
Also called NCT03338010
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 536 participants
- Sponsor
- Registry
-
NCT03338010
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03338010. Randomized; no masking; primary purpose treatment. Start 2018-03-22 (actual); primary completion 2020-03-18 (actual). Results posted on 2021-05-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- LY2963016
- Intervention (Drug)
- Lantus®
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct03338010- Content hash
547582e0d661413156327395052427a99ea9921abea12d82ca94fb990ebe25bf